HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of necrotising fasciitis in a patient treated for rheumatoid arthritis with tocilizumab.

AuthorsNoriko Hashimoto, Toshifumi Yamaoka, Hanako Koguchi-Yoshioka, Aya Tanaka, Atsushi Tanemura, Hiroaki Azukizawa, Hiroyuki Murota, Jinkoo Kang, Yuko Nakagawa, Takeshi Shimazu, Ichiro Katayama
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 95 Issue 3 Pg. 370-1 (Mar 2015) ISSN: 1651-2057 [Electronic] Sweden
PMID25138684 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • tocilizumab
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Antibodies, Monoclonal, Humanized (adverse effects)
  • Antirheumatic Agents (administration & dosage)
  • Arthritis, Rheumatoid (diagnosis, drug therapy, immunology)
  • Biopsy
  • Combined Modality Therapy
  • Debridement
  • Fasciitis, Necrotizing (chemically induced, diagnosis, microbiology, therapy)
  • Humans
  • Male
  • Middle Aged
  • Skin Transplantation
  • Streptococcal Infections (chemically induced, diagnosis, microbiology, therapy)
  • Treatment Outcome
  • Wound Healing
  • Wound Infection (chemically induced, diagnosis, microbiology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: